Andrey Ivashchenko, Head of the ChemRar Group, was awarded the title of «Honorary Worker of the Pharmaceutical Industry»
On May 19, 2025, as part of the celebration of the Day of the Pharmaceutical Worker of Russia, established last year by the Ministry of Industry and Trade of the Russian Federation, the first solemn ceremony was held to award pharmaceutical industry workers to the management staff of pharmaceutical companies, representatives of industry associations and government agencies who have made a significant contribution to the development of the pharmaceutical industry of the Russian Federation.
During the ceremony, Anton Alikhanov, Minister of Industry and Trade of the Russian Federation, congratulated the audience on their professional holiday and presented honorary insignia «Honorary Worker of the Pharmaceutical Industry».
ChemRar Group, represented by its Head and Chairman of the Board of Directors Andrey Alexandrovich Ivashchenko, was recognized for its outstanding achievements and significant contribution to the development of the pharmaceutical industry of the Russian Federation, including the implementation of the Strategy for the Development of the Pharmaceutical Industry of the Russian Federation for the period up to 2020, as well as for achieving high production performance and the successful development of a new competitive products that meet modern industry requirements.
Andrey Ivashchenko, Doctor of Technical Sciences, Professor of the Russian Academy of Sciences, thanked for the high appreciation on behalf of the entire team of ChemRar Group: «I perceive this award as the award of our entire team, which this year turns 35 years old. As you know, the main focus of our work is the development and market launch of domestic innovative drugs. By creating new drugs, we focus not only on the market and the needs of the healthcare system, but above all we are guided by the mission of our organization, which we have defined for ourselves as «Why does the world need us?» It reflects the values and principles on which we strive to ensure that people in Russia and around the world stop suffering and dying from diseases for which there is already a cure. And if there is no such medicine yet, but there are ideas for their creation, then we will make every effort to ensure that such medicines appear as soon as possible.»
Over the past 10 years, including with the support of the Pharma 2020 program, ChemRar Group has developed and marketed, and importantly, produces a number of medicines that are significant for our country, including the world’s best in its class and the 1st In the 21st century, a domestic innovative drug for the treatment of HIV infection is ELPIDA®.
In June 2020, AVIFAVIR®, a direct antiviral drug for the treatment of COVID-19, was registered as the first in the world, thanks to which hundreds of thousands of lives were saved in Russia and other countries.
In 2024, AVIANDR®, an innovative new-generation drug for the treatment of anxiety disorders and depression, including after a coronavirus infection, was registered and launched on the Russian market. It was invented by our scientists and is a world-class innovation.
Innovative drugs in the field of oncology, diabetes, hepatitis C virus control, AIDS, and pathogenic influenza are currently in clinical research and are being registered.
The award ceremony became an important event in the professional life of the industry’s employees and highlighted the appreciation of their many years of conscientious work on the development of the domestic pharmaceutical industry. «On this day, congratulations to thousands of specialists whose solutions and efforts, developments and endless dedication have made it possible to turn Russian pharma into a driver of scientific and technological progress throughout the country,» the Russian Ministry of Industry and Trade said in an official press release.